The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes

PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2015-03, Vol.34 (11), p.1363-1374
Hauptverfasser: O'Flanagan, C H, Morais, V A, Wurst, W, De Strooper, B, O'Neill, C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1374
container_issue 11
container_start_page 1363
container_title Oncogene
container_volume 34
creator O'Flanagan, C H
Morais, V A
Wurst, W
De Strooper, B
O'Neill, C
description PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1 −/− mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1 −/− mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1 −/− cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.
doi_str_mv 10.1038/onc.2014.81
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668253297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A406163896</galeid><sourcerecordid>A406163896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</originalsourceid><addsrcrecordid>eNp9kctu1TAQhi0EoofCqnsUqZtKkIPvsZdVVaCialmUteU4kzQlsU_tZHF2fQ1ejyfB4ZRLUYW8sDzzzfif-RE6IHhNMFPvgndriglfK_IErQivZCmE5k_RCmuBS00Z3UMvUrrBGFca0-doj3KpiBbVCnVX11B8tvFr71Pw3---paIDn0NnF59IEaGbBztBKhwMQ-G2boBiE0MXIaU--ML6ZnmP4SdjvYNY2pSC63NVTl2DD9N2A-kletbaIcGr-3sffXl_enXysTy__HB2cnxeOkmqqSSOW6vAYs2UpILjWkmnGm6Z4G3dSJbn1FzVra6VFUq3jW200gpLS0C0wPbR0a5vVnU7Q5rM2KdFvPUQ5mSIlIoKRnWV0cN_0JswR5_VGcoYkSTvi_yPyr3yIkmG_1CdHcD0vg1TtG752hxzLIlkSstMrR-h8mlg7F3w0PY5_qDgza7AxZBShNZsYj_auDUEm8V8k803i_lGLVJf30ud6xGa3-wvtzPwdgeknPIdxL9meaTfD59Ct34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1662461233</pqid></control><display><type>article</type><title>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>O'Flanagan, C H ; Morais, V A ; Wurst, W ; De Strooper, B ; O'Neill, C</creator><creatorcontrib>O'Flanagan, C H ; Morais, V A ; Wurst, W ; De Strooper, B ; O'Neill, C</creatorcontrib><description>PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1 −/− mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1 −/− mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1 −/− cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2014.81</identifier><identifier>PMID: 24681957</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/420/755 ; 692/699/67 ; Animals ; Apoptosis ; Cancer ; Cell Biology ; Cell cycle ; Cell division ; Cell Division - genetics ; Cell Line, Tumor ; Cell Movement ; Cell proliferation ; Cell Proliferation - genetics ; Cell survival ; Cellular biology ; Chemotherapy ; Chromosome 10 ; Clonal deletion ; Cyclin D1 ; Cyclin D1 - biosynthesis ; Cytokinesis ; Cytokinesis - genetics ; Dynamin ; Ectopic expression ; Embryo fibroblasts ; Embryos ; Gene Expression Regulation, Neoplastic - genetics ; Genetic aspects ; Genotype &amp; phenotype ; GTP Phosphohydrolases - metabolism ; HeLa Cells ; Human Genetics ; Humans ; Internal Medicine ; Invasiveness ; Kinases ; M Phase Cell Cycle Checkpoints - genetics ; MCF-7 Cells ; Medicine ; Medicine &amp; Public Health ; Metastases ; Mice ; Mice, Knockout ; Microtubule-Associated Proteins - metabolism ; Mitochondria ; Mitochondria - genetics ; Mitochondria - pathology ; Mitochondrial Proteins - metabolism ; Mitosis ; Movement disorders ; Neoplasm Invasiveness - genetics ; Neurodegenerative diseases ; Nocodazole ; Oncology ; original-article ; Parkinson Disease - genetics ; Parkinson's disease ; Phenotypes ; Protein Kinases - biosynthesis ; Protein Kinases - genetics ; Protein Kinases - metabolism ; PTEN protein ; Ribonucleic acid ; Risk factors ; RNA ; RNA Interference ; RNA, Small Interfering</subject><ispartof>Oncogene, 2015-03, Vol.34 (11), p.1363-1374</ispartof><rights>Macmillan Publishers Limited 2015</rights><rights>COPYRIGHT 2015 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Mar 12, 2015</rights><rights>Macmillan Publishers Limited 2015.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</citedby><cites>FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/onc.2014.81$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/onc.2014.81$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27911,27912,41475,42544,51306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24681957$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Flanagan, C H</creatorcontrib><creatorcontrib>Morais, V A</creatorcontrib><creatorcontrib>Wurst, W</creatorcontrib><creatorcontrib>De Strooper, B</creatorcontrib><creatorcontrib>O'Neill, C</creatorcontrib><title>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1 −/− mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1 −/− mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1 −/− cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.</description><subject>692/420/755</subject><subject>692/699/67</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell cycle</subject><subject>Cell division</subject><subject>Cell Division - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - genetics</subject><subject>Cell survival</subject><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Chromosome 10</subject><subject>Clonal deletion</subject><subject>Cyclin D1</subject><subject>Cyclin D1 - biosynthesis</subject><subject>Cytokinesis</subject><subject>Cytokinesis - genetics</subject><subject>Dynamin</subject><subject>Ectopic expression</subject><subject>Embryo fibroblasts</subject><subject>Embryos</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Genetic aspects</subject><subject>Genotype &amp; phenotype</subject><subject>GTP Phosphohydrolases - metabolism</subject><subject>HeLa Cells</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Invasiveness</subject><subject>Kinases</subject><subject>M Phase Cell Cycle Checkpoints - genetics</subject><subject>MCF-7 Cells</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Microtubule-Associated Proteins - metabolism</subject><subject>Mitochondria</subject><subject>Mitochondria - genetics</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial Proteins - metabolism</subject><subject>Mitosis</subject><subject>Movement disorders</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neurodegenerative diseases</subject><subject>Nocodazole</subject><subject>Oncology</subject><subject>original-article</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson's disease</subject><subject>Phenotypes</subject><subject>Protein Kinases - biosynthesis</subject><subject>Protein Kinases - genetics</subject><subject>Protein Kinases - metabolism</subject><subject>PTEN protein</subject><subject>Ribonucleic acid</subject><subject>Risk factors</subject><subject>RNA</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kctu1TAQhi0EoofCqnsUqZtKkIPvsZdVVaCialmUteU4kzQlsU_tZHF2fQ1ejyfB4ZRLUYW8sDzzzfif-RE6IHhNMFPvgndriglfK_IErQivZCmE5k_RCmuBS00Z3UMvUrrBGFca0-doj3KpiBbVCnVX11B8tvFr71Pw3---paIDn0NnF59IEaGbBztBKhwMQ-G2boBiE0MXIaU--ML6ZnmP4SdjvYNY2pSC63NVTl2DD9N2A-kletbaIcGr-3sffXl_enXysTy__HB2cnxeOkmqqSSOW6vAYs2UpILjWkmnGm6Z4G3dSJbn1FzVra6VFUq3jW200gpLS0C0wPbR0a5vVnU7Q5rM2KdFvPUQ5mSIlIoKRnWV0cN_0JswR5_VGcoYkSTvi_yPyr3yIkmG_1CdHcD0vg1TtG752hxzLIlkSstMrR-h8mlg7F3w0PY5_qDgza7AxZBShNZsYj_auDUEm8V8k803i_lGLVJf30ud6xGa3-wvtzPwdgeknPIdxL9meaTfD59Ct34</recordid><startdate>20150312</startdate><enddate>20150312</enddate><creator>O'Flanagan, C H</creator><creator>Morais, V A</creator><creator>Wurst, W</creator><creator>De Strooper, B</creator><creator>O'Neill, C</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20150312</creationdate><title>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</title><author>O'Flanagan, C H ; Morais, V A ; Wurst, W ; De Strooper, B ; O'Neill, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>692/420/755</topic><topic>692/699/67</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell cycle</topic><topic>Cell division</topic><topic>Cell Division - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - genetics</topic><topic>Cell survival</topic><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Chromosome 10</topic><topic>Clonal deletion</topic><topic>Cyclin D1</topic><topic>Cyclin D1 - biosynthesis</topic><topic>Cytokinesis</topic><topic>Cytokinesis - genetics</topic><topic>Dynamin</topic><topic>Ectopic expression</topic><topic>Embryo fibroblasts</topic><topic>Embryos</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Genetic aspects</topic><topic>Genotype &amp; phenotype</topic><topic>GTP Phosphohydrolases - metabolism</topic><topic>HeLa Cells</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Invasiveness</topic><topic>Kinases</topic><topic>M Phase Cell Cycle Checkpoints - genetics</topic><topic>MCF-7 Cells</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Microtubule-Associated Proteins - metabolism</topic><topic>Mitochondria</topic><topic>Mitochondria - genetics</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial Proteins - metabolism</topic><topic>Mitosis</topic><topic>Movement disorders</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neurodegenerative diseases</topic><topic>Nocodazole</topic><topic>Oncology</topic><topic>original-article</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson's disease</topic><topic>Phenotypes</topic><topic>Protein Kinases - biosynthesis</topic><topic>Protein Kinases - genetics</topic><topic>Protein Kinases - metabolism</topic><topic>PTEN protein</topic><topic>Ribonucleic acid</topic><topic>Risk factors</topic><topic>RNA</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Flanagan, C H</creatorcontrib><creatorcontrib>Morais, V A</creatorcontrib><creatorcontrib>Wurst, W</creatorcontrib><creatorcontrib>De Strooper, B</creatorcontrib><creatorcontrib>O'Neill, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Flanagan, C H</au><au>Morais, V A</au><au>Wurst, W</au><au>De Strooper, B</au><au>O'Neill, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2015-03-12</date><risdate>2015</risdate><volume>34</volume><issue>11</issue><spage>1363</spage><epage>1374</epage><pages>1363-1374</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1 −/− mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1 −/− mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1 −/− cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>24681957</pmid><doi>10.1038/onc.2014.81</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2015-03, Vol.34 (11), p.1363-1374
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_miscellaneous_1668253297
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Nature Journals Online; SpringerLink Journals - AutoHoldings
subjects 692/420/755
692/699/67
Animals
Apoptosis
Cancer
Cell Biology
Cell cycle
Cell division
Cell Division - genetics
Cell Line, Tumor
Cell Movement
Cell proliferation
Cell Proliferation - genetics
Cell survival
Cellular biology
Chemotherapy
Chromosome 10
Clonal deletion
Cyclin D1
Cyclin D1 - biosynthesis
Cytokinesis
Cytokinesis - genetics
Dynamin
Ectopic expression
Embryo fibroblasts
Embryos
Gene Expression Regulation, Neoplastic - genetics
Genetic aspects
Genotype & phenotype
GTP Phosphohydrolases - metabolism
HeLa Cells
Human Genetics
Humans
Internal Medicine
Invasiveness
Kinases
M Phase Cell Cycle Checkpoints - genetics
MCF-7 Cells
Medicine
Medicine & Public Health
Metastases
Mice
Mice, Knockout
Microtubule-Associated Proteins - metabolism
Mitochondria
Mitochondria - genetics
Mitochondria - pathology
Mitochondrial Proteins - metabolism
Mitosis
Movement disorders
Neoplasm Invasiveness - genetics
Neurodegenerative diseases
Nocodazole
Oncology
original-article
Parkinson Disease - genetics
Parkinson's disease
Phenotypes
Protein Kinases - biosynthesis
Protein Kinases - genetics
Protein Kinases - metabolism
PTEN protein
Ribonucleic acid
Risk factors
RNA
RNA Interference
RNA, Small Interfering
title The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A46%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Parkinson%E2%80%99s%20gene%20PINK1%20regulates%20cell%20cycle%20progression%20and%20promotes%20cancer-associated%20phenotypes&rft.jtitle=Oncogene&rft.au=O'Flanagan,%20C%20H&rft.date=2015-03-12&rft.volume=34&rft.issue=11&rft.spage=1363&rft.epage=1374&rft.pages=1363-1374&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/onc.2014.81&rft_dat=%3Cgale_proqu%3EA406163896%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1662461233&rft_id=info:pmid/24681957&rft_galeid=A406163896&rfr_iscdi=true